A simple blood test can help detect cancer in patients with non-specific symptoms such as fatigue, pain or weight loss. This ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
Abstract: High dimensionality is one the major problem in the classification of microarray gene expression data. Most of the classifiers performed well for the data having same number of features as ...
The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...
Every minute, four Americans are told they have cancer and start a journey into one of the most complex diseases in medicine. Now, a new AI tool developed by Microsoft Research and covered today in a ...
The study’s findings track with recent research on the alarming rise of the cancer in younger adults. By Alice Callahan About 15 years ago, Dr. Andrew T. Chan, a gastroenterologist at Mass General ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback